Theratechnologies inc.

Theratechnologies inc.

November 30, 2007 14:42 ET

Theratechnologies to Present at BMO Capital Markets Focus on Healthcare Conference in New York

MONTREAL, QUEBEC--(Marketwire - Nov. 30, 2007) - Theratechnologies (TSX:TH) announced today that Yves Rosconi, President and Chief Executive Officer, will present an overview of Theratechnologies at the 7th Annual Focus on Healthcare Conference hosted by BMO Capital Markets at 3:30 p.m. on Tuesday, December 4, 2007, at the Millennium Broadway Hotel in New York City.

A live webcast of the presentation will be available at the following address:
The presentation will also be archived for further reference.

About Theratechnologies

Theratechnologies (TSX:TH) is a Canadian biopharmaceutical company that discovers innovative drug candidates in order to develop them and bring them to market. The Company targets unmet medical needs in financially attractive specialty markets. Its most advanced program is tesamorelin, now in a confirmatory Phase 3 clinical trial for a serious metabolic disorder known as HIV-associated lipodystrophy. The Company also has other projects at earlier stages of development.

Contact Information